The effect of pregabalin and s-ketamine in total knee arthroplasty patients: A randomized trial.

J Anaesthesiol Clin Pharmacol

Department of Orthopaedics, Pain and Palliative Medicine, Radboud University, Nijmegen Medical Centre, The Netherlands.

Published: January 2016

Background And Aims: Pain reduction is important for rehabilitation after total knee arthroplasty. Intra- and peri-articular infiltration with local anesthetics may be an alternative to commonly used locoregional techniques. Adding pregabalin orally and s-ketamine intravenously may further reduce postoperative pain.

Material And Methods: This prospective, randomized, double-blind, placebo-controlled study compared two methods of perioperative analgesia. Control patients received a standardized multimodal postoperative analgesic regime of paracetamol, diclofenac, and piritramide-patient-controlled analgesia, including ropivacaine knee infiltration during surgery. The study group received pregabalin orally and s-ketamine intravenously as an additional medication to the standard multimodal regimen. The control group received placebo.

Results: The study group showed lower piritramide consumption during the first 24 h (P: 0.043), but with more side effects such as diplopia and dizziness.

Conclusion: Addition of pregabalin and s-ketamine resulted in lower piritramide consumption during the first 24 h postoperatively. However, more investigation on benefits versus side effects of this medication is required.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187612PMC
http://dx.doi.org/10.4103/0970-9185.194762DOI Listing

Publication Analysis

Top Keywords

pregabalin s-ketamine
8
total knee
8
knee arthroplasty
8
pregabalin orally
8
orally s-ketamine
8
s-ketamine intravenously
8
study group
8
group received
8
lower piritramide
8
piritramide consumption
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!